Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:05 AM
NCT ID: NCT03102918
Description: Study staff collected any adverse event data during every study visit for each subject. This amounted to twice a week during the study.
Frequency Threshold: 0
Time Frame: Adverse event data was collected through-out the course of the study during each study visit. This is from baseline until Week 14 when the last follow-up visit was conducted.
Study: NCT03102918
Study Brief: Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Cannabidiol Epidiolex Cannabidiol: Participants will receive either up to 800 mg Epidiolex over a 6-week treatment period. 0 None 0 5 0 5 View
Placebo Placebo Placebo: Participants will receive placebo over a 6-week treatment period. 0 None 0 5 0 5 View
Serious Events(If Any):
Other Events(If Any):